- By ICR Secretariat
- Posted Wednesday, February 17, 2021
CureVac’s COVID-19 vaccine begins rolling review with EMA
http://www.pharmatimes.com/news/curevacs_covid-19_vaccine_begins_rolling_review_with_ema_1363316
German biopharmaceutical company CureVac has announced the initiation of a rolling review with the European Medicines Agency (EMA) for its mRNA-based COVID-19 vaccine, CVnCoV.
The oldest independent membership-led professional body for clinical researchers across the globe.
Latest Posts
- ONLY 2 WEEKS to go until Ethics & GCP Forum - Thursday 18th March (1) 04/03/2021 03:55 PM
- Moderna, Pfizer ready multi-pronged plans for coronavirus variants 04/03/2021 02:17 PM
- ICON to acquire PRA Health Sciences in $12bn deal 04/03/2021 02:16 PM
Useful Links
Contact Us
Suite 10, Cedar Court
Grove Park
White Waltham
Maidenhead
SL6 3LW
info@icr-global.org